J. Jankowski et al., Isolation and characterization of coenzyme A glutathione disulfide as a parathyroid-derived vasoconstrictive factor, CIRCULATION, 102(20), 2000, pp. 2548-2552
Citations number
32
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-Coenzyme A glutathione disulfide (CoA-SSG) was recently isolated
from bovine adrenal glands and was shown to be a renal vasoconstrictor. Th
e identification of CoA-SSG in human parathyroid glands and its action on c
ultured vascular smooth muscle cells (VSMCs) are described here.
Methods and Results-After purification to homogeneity by several chromatogr
aphic steps, CoA-SSG was identified by matrix-assisted laser desorption/ion
ization mass spectrometry and enzymatic analysis. The dose-dependent growth
-stimulating effect of CoA-SSG on VSMCs, measured by the [H-3]thymidine met
hod, is characterized by a threshold of 10(-8) mol/L and a maximum effect o
f 10 mu mol/L, increasing VSMC proliferation 254+/-21% above control. A dos
e of 10 mu mol/L methylmalonyl-CoA and 10 mu mol/L CoA increased the rate o
f proliferation of VSMCs only by 178+/-43% and 50+/-42% above control. resp
ectively. Glutathione has no proliferative effect on VSMCs. The growth-stim
ulating effect of CoA-SSG (1 mu mol/L) was decreased by the antagonists 3,7
-dimethyl-1-propargylxanthine (DMPX; 11 mu mol/L) (38% compared with CoA-SS
G without antagonist) and pyridoxal-phosphate-6-azophenyl-2,4-disulfonic ac
id (PPADS; 10 mu mol/L) (48% compared with CoA-SSG without antagonist; each
P<0.05 versus control), indicating that the effect is mediated partly via
A, and partly via P2Y1 and/or P2Y4 receptor.
Conclusions-CoA-SSG may play a regulatory role in VSMC growth as a progress
ion factor and thereby could play an important role in development of hyper
tension.